Status:
COMPLETED
Factors That Effect the Gait Speed in Diabetic Individuals Without Neuropathy
Lead Sponsor:
GULIN FINDIKOGLU
Conditions:
Gait Disorder, Sensorimotor
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-75 years
Brief Summary
This study planned to investigate the role of potential explanatory factors effecting the speed of gait such as muscle mass, aerobic capacity, physical activity status, cognitive function, blood press...
Detailed Description
Type 2 diabetic people will be screened by clinical symptoms of neuropathy and DN4 questionnaire. Among those who did not have neuropathic symptoms or who have DN4 score below 4 will be considered for...
Eligibility Criteria
Inclusion
- Individuals with Diabetes Mellitus less than 10 years but longer than 1 year
- Absence of neuropathic symptoms
- DN4 questionnaire sore less than 4
Exclusion
- Individuals who had
- insulin therapy,
- poor glycemic control,
- manifesting cardiovascular disease,
- retinopathy or other visual problems,
- diabetic neuropathy,
- nephropathy,
- cerebrovascular disease,
- cognitive impairment,
- heart failure,
- alcohol or cigarette dependence,
- cancer,
- chemo/radiotherapy,
- foot ulcer,
- orthopedical or surgical problems
- wheel-chair or any assistive devices for ambulation
- prominent knee or hip arthritis, prosthesis
Key Trial Info
Start Date :
February 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04758364
Start Date
February 20 2021
End Date
March 30 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Turkey (Türkiye), 21600